CA2103046A1 - Hybridome de lymphocytes t suppresseurs - Google Patents

Hybridome de lymphocytes t suppresseurs

Info

Publication number
CA2103046A1
CA2103046A1 CA002103046A CA2103046A CA2103046A1 CA 2103046 A1 CA2103046 A1 CA 2103046A1 CA 002103046 A CA002103046 A CA 002103046A CA 2103046 A CA2103046 A CA 2103046A CA 2103046 A1 CA2103046 A1 CA 2103046A1
Authority
CA
Canada
Prior art keywords
gif
antigen
human
cell line
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002103046A
Other languages
English (en)
Inventor
Kimishige Ishizaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Jolla Institute for Allergy and Immunology
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2103046A1 publication Critical patent/CA2103046A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002103046A 1991-06-03 1992-06-03 Hybridome de lymphocytes t suppresseurs Abandoned CA2103046A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70937591A 1991-06-03 1991-06-03
US709,375 1991-06-03

Publications (1)

Publication Number Publication Date
CA2103046A1 true CA2103046A1 (fr) 1992-12-04

Family

ID=24849607

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002103046A Abandoned CA2103046A1 (fr) 1991-06-03 1992-06-03 Hybridome de lymphocytes t suppresseurs

Country Status (8)

Country Link
EP (1) EP0591320A4 (fr)
JP (1) JPH06508829A (fr)
AU (1) AU2161792A (fr)
CA (1) CA2103046A1 (fr)
FI (1) FI934989A (fr)
HU (1) HUT67010A (fr)
NO (1) NO934382L (fr)
WO (1) WO1992021240A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3578787B2 (ja) * 1993-05-14 2004-10-20 ラホヤ インスティチュート フォア アレルギー アンド イムノロジー 生物学的に活性なポリペプチドの組換え製造方法
WO2014192877A1 (fr) * 2013-05-29 2014-12-04 Jsr株式会社 Composition de lavage, procédé de purification de protéine, et protéine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0285405A1 (fr) * 1987-03-31 1988-10-05 Schering Biotech Corporation Facteur d'inhibition de la glycosylation

Also Published As

Publication number Publication date
HU9303380D0 (en) 1994-03-28
EP0591320A4 (fr) 1994-11-23
WO1992021240A1 (fr) 1992-12-10
FI934989A (fi) 1993-12-01
NO934382D0 (no) 1993-12-02
AU2161792A (en) 1993-01-08
EP0591320A1 (fr) 1994-04-13
FI934989A0 (fi) 1993-11-11
NO934382L (no) 1994-02-02
HUT67010A (en) 1995-01-30
JPH06508829A (ja) 1994-10-06

Similar Documents

Publication Publication Date Title
RU2082428C1 (ru) СПОСОБ ПОЛУЧЕНИЯ АНТИТЕЛ, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩИХСЯ С Ig E
AU687897B2 (en) Immunoreactive peptide sequence from a 43 KD human cancer antigen
KR100584051B1 (ko) 알레르기에 대한 백신 접종 및 치료를 위한 펩티드임뮤노겐
WO1992007574A1 (fr) Glycoproteines associees a des immunoglobulines a liaison membranaire et utilisees comme cibles anticorpales sur des cellules b
JPH07126300A (ja) ヒトのｂ細胞受容体複合体の特異抗原を認識するモノクローナル抗体
WO1992014756A1 (fr) Peptides et fragments de peptides efficaces therapeutiquement
JPH04506359A (ja) ヒトインターロイキン―４の抗体アンタゴニスト
JPH10504284A (ja) 抗原パルス化樹状細胞によるｉｎ ｖｉｖｏ Ｔ細胞活性化法
JPH01501939A (ja) 免疫抑制ペプチドおよび使用法
US5723582A (en) Antigen-specific human glycosylation inhibiting factor
Shimizu et al. Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells
JPH05503687A (ja) 自己免疫疾患の治療
JPH08149981A (ja) Ｔ細胞α鎖による抗原特異的免疫制御の方法
JP3578787B2 (ja) 生物学的に活性なポリペプチドの組換え製造方法
EP0957111B1 (fr) Protéines de liaison spécifiques pour le traitement des allergies canines
CA2103046A1 (fr) Hybridome de lymphocytes t suppresseurs
Fehlner et al. Murine T cell responses to melittin and its analogs.
Scherer et al. Control of cellular and humoral immune responses by peptides containing T-cell epitopes
AU707739B2 (en) Suppressor T-cell hybridoma
US5786168A (en) Method for recombinant production of antigen non-specific glycosylation inhibiting factor (GIF)
AU757334B2 (en) Specific binding proteins for treating canine allergy
EP0955311A2 (fr) Vaccin peptidique contre l'allergie des chiens
WO1996031617A1 (fr) Methode de production de facteur bloquant la glycosylation (gif) specifique de l'antigene
Malley et al. The Role of l-J+ Macrophages in the Induction of Antigen B-Specific T-Suppressor Cells
JP2004149507A (ja) 免疫抑制剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead